Search

Search bills, members, committees and pages...

Sign In

TAKEDA PHARMACEUTICALS AMERICA INC

PreviousNext

19 federal lobbying filings, 2023 to 2026.

TAKEDA PHARMACEUTICALS AMERICA INC is a client on 19 federal lobbying filings, 2023 to 2026, reporting $80K across them. Pharmaceutical Manufacturing Based in District of Columbia.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.

Firms

2 it has hired, by filings.

RegistrantFilingsReported
TAKEDA PHARMACEUTICALS AMERICA, INC.16—
FARRAGUT PARTNERS LLP3$80K

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
20265$80K$2M
20255—$5.5M
20245—$3.3M
20234—$4.6M

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
HCRHealth Issues19
MMMMedicare/Medicaid16
TRDTrade (domestic/foreign)16
BUDBudget/Appropriations15
TAXTaxation/Internal Revenue Code15
DEFDefense12

Bills

The bills the filings name, by how many name them.

BillTitleFilings
H.R. 1An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.7
S. 832EPIC Act of 20257
H.R. 946ORPHAN Cures Act6
H.R. 4229To amend the Impoundment Control Act of 1974 to require prior approval from Congress before the Comptroller G…4
H.R. 1476PLASMA Act3
H.R. 2214DRUG Act3
S. 694PLASMA Act3
H.R. 7299To designate the facility of the United States Postal Service located at 2600 Michigan Avenue in Kissimmee, F…2
H.R. 2528Association Health Plans Act1
H.R. 4299Protecting Patient Access to Cancer and Complex Therapies Act1

Lobbyists

Named on the filings.

LobbyistClientsFilings
ANDREW KAPLAN116
SHELLEY STEWART116
KIRSTEN POWELL113
REBECCA MANDELL111
ERIN MENDELSOHN14
NATALIE MORRIS14
CONSTANTINE HINGSON13
DYLAN MOORE13
EDWARD WHITFIELD13
JEFFERY MORTIER13
JODY GALE13
KRISTEN BAUTZ13
SARAH WALTER13
STEVEN TILTON13
WILLIAM KRIEGER13
NICHOLAS LISOWSKI12
RICHARD CHALKEY12
JEFF MACKINNON11
NICK LISOWSKI11
R CODY CHALKEY11

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
TAKEDA PHARMACEUTICALS AMERICA INCTAKEDA PHARMACEUTICALS AMERICA, INC.2026 second_quarter$610KJul 20, 2026
TAKEDA PHARMACEUTICALS AMERICA INCFARRAGUT PARTNERS LLP2026 second_quarter$40KJul 20, 2026
TAKEDA PHARMACEUTICALS AMERICA INCFARRAGUT PARTNERS LLP2026 first_quarter$40KJul 1, 2026
TAKEDA PHARMACEUTICALS AMERICA INCFARRAGUT PARTNERS LLP2026 first_quarter—Jun 30, 2026
TAKEDA PHARMACEUTICALS AMERICA INCTAKEDA PHARMACEUTICALS AMERICA, INC.2026 first_quarter$1.4MApr 20, 2026
TAKEDA PHARMACEUTICALS AMERICA INCTAKEDA PHARMACEUTICALS AMERICA, INC.2025 fourth_quarter$590KJan 20, 2026
TAKEDA PHARMACEUTICALS AMERICA INCTAKEDA PHARMACEUTICALS AMERICA, INC.2025 third_quarter$1.4MOct 20, 2025
TAKEDA PHARMACEUTICALS AMERICA INCTAKEDA PHARMACEUTICALS AMERICA, INC.2025 second_quarter$1.6MAug 26, 2025
TAKEDA PHARMACEUTICALS AMERICA INCTAKEDA PHARMACEUTICALS AMERICA, INC.2025 second_quarter$1.5MJul 21, 2025
TAKEDA PHARMACEUTICALS AMERICA INCTAKEDA PHARMACEUTICALS AMERICA, INC.2025 first_quarter$490KApr 22, 2025
TAKEDA PHARMACEUTICALS AMERICA INCTAKEDA PHARMACEUTICALS AMERICA, INC.2024 fourth_quarter$390KApr 18, 2025
TAKEDA PHARMACEUTICALS AMERICA INCTAKEDA PHARMACEUTICALS AMERICA, INC.2024 fourth_quarter$380KJan 21, 2025
TAKEDA PHARMACEUTICALS AMERICA INCTAKEDA PHARMACEUTICALS AMERICA, INC.2024 third_quarter$970KOct 18, 2024
TAKEDA PHARMACEUTICALS AMERICA INCTAKEDA PHARMACEUTICALS AMERICA, INC.2024 second_quarter$1.1MJul 22, 2024
TAKEDA PHARMACEUTICALS AMERICA INCTAKEDA PHARMACEUTICALS AMERICA, INC.2024 first_quarter$460KApr 22, 2024
TAKEDA PHARMACEUTICALS AMERICA INCTAKEDA PHARMACEUTICALS AMERICA, INC.2023 fourth_quarter$510KJan 19, 2024
TAKEDA PHARMACEUTICALS AMERICA INCTAKEDA PHARMACEUTICALS AMERICA, INC.2023 third_quarter$1.4MOct 20, 2023
TAKEDA PHARMACEUTICALS AMERICA INCTAKEDA PHARMACEUTICALS AMERICA, INC.2023 second_quarter$1.3MJul 20, 2023
TAKEDA PHARMACEUTICALS AMERICA INCTAKEDA PHARMACEUTICALS AMERICA, INC.2023 first_quarter$1.5MApr 20, 2023